期刊
CELLS
卷 11, 期 22, 页码 -出版社
MDPI
DOI: 10.3390/cells11223698
关键词
IL-6; cancer; metastasis
类别
资金
- Operational Programme Research, Development and Education, within the projects: Centre for Tumour Ecology-Research of the Cancer Microenvironment Supporting Cancer Growth and Spread [CZ.02.1.01/0.0/0.0/16_019/0000785]
- European Union-Next Generation EU [LX22NPO5102]
- Ministry of Education, Youth and Sports [LM2018133]
- Ministry of Health of the Czech Republic [NU21-08-00407, NU22-D-136]
This review summarizes the role of interleukin 6 (IL-6) in cancer biology, highlighting the potential of targeting IL-6 signaling pathways, particularly in metastasis suppression.
Interleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various homeostatic and pathological processes. These activities range from regulating embryonic development, wound healing and ageing, inflammation, and immunity, including COVID-19. In this review, we summarise the role of IL-6 signalling pathways in cancer biology, with particular emphasis on cancer cell invasiveness and metastasis formation. Targeting principal components of IL-6 signalling (e.g., IL-6Rs, gp130, STAT3, NF-kappa B) is an intensively studied approach in preclinical cancer research. It is of significant translational potential; numerous studies strongly imply the remarkable potential of IL-6 signalling inhibitors, especially in metastasis suppression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
